scispace - formally typeset
K

Kanneboyina Nagaraju

Researcher at Binghamton University

Publications -  189
Citations -  9970

Kanneboyina Nagaraju is an academic researcher from Binghamton University. The author has contributed to research in topics: Duchenne muscular dystrophy & Skeletal muscle. The author has an hindex of 52, co-authored 181 publications receiving 8793 citations. Previous affiliations of Kanneboyina Nagaraju include Children's National Medical Center & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Endothelial cell activation and neovascularization are prominent in dermatomyositis

TL;DR: Gene expression analysis demonstrated that genes that participate not only in angiogenesis but also in leukocyte trafficking and the complement cascade were highly up regulated in DM muscle in comparison to age matched controls.
Journal ArticleDOI

Long-term efficacy of systemic multiexon skipping targeting dystrophin exons 45-55 with a cocktail of vivo-morpholinos in mdx52 mice.

TL;DR: A new regimen with the 10-Vivo-Morpholino cocktail is effective and safe for long-term repeated systemic administration in the dystrophic mouse model and exhibits the restoration of 5-27% of normal levels of dystrophin protein in skeletal muscles, accompanied by improvements in histopathology and muscle strength.
Journal ArticleDOI

Novel fragments of the Sjögren's syndrome autoantigens α‐fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule–induced cell death

TL;DR: The observation that both ubiquitously expressed autoantigens targeted in Sjögren's syndrome are specifically cleaved by granzyme B, generating unique fragments strongly suggests that a common biochemical event is responsible for selecting this apparently unconnected group of molecules for a high-titer autoantibody response.
Journal ArticleDOI

Glycogen Stored in Skeletal but Not in Cardiac Muscle in Acid α-Glucosidase Mutant (Pompe) Mice Is Highly Resistant to Transgene-Encoded Human Enzyme

TL;DR: It is demonstrated that levels of 20-30% of normal activity are indeed sufficient to clear glycogen in the heart of young Gaa(-/-) mice, but not in older mice with a considerably higher glycogen load, and in skeletal muscle some muscle fibers showed little or no glycogen clearance.
Journal ArticleDOI

Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice.

TL;DR: Testing of all new molecules/drugs using a widely accepted and agreed upon standard experimental protocol would greatly improve the power of pre-clinical experimentations and help identifying promising therapies for the translation into clinical trials for boys with Duchenne Muscular Dystrophy.